The Latest Cardiac and Vascular News
LAVAL, Québec, May 23, 2019 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) announced that it has completed the previously disclosed issuance of 900,000 common shares from treasury to its former chief executive officer (the “Former CEO”) pursuant to the terms of a settlement agreement […]
Rouen, France, May 21, 2019 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, announces today that Pr Haude, Dr Lorgat and Pr Nef have joined its medical advisory board. All are global experts and recognized leaders in interventional cardiology. The board […]
Q4 Revenue of $8.1 Billion, Flat as Reported and Grew 3.6% Organic Q4 GAAP Diluted EPS of $0.87; Q4 Non-GAAP Diluted EPS of $1.54 FY19 Revenue of $30.6 Billion Grew 2.0% Reported and 5.5% Organic FY19 GAAP Diluted EPS of $3.41; FY19 Non-GAAP Diluted EPS of $5.22 FY19 Cash Flow […]
SAN DIEGO–(BUSINESS WIRE)–Sotera Wireless, maker of the ViSi Mobile® Surveillance Monitoring System and a pioneer in continuous vital signs monitoring, announced today the appointment of veteran engineering and operations executive Younes Achkire, PhD, as its new Chief Operating Officer. With a doctorate from the Free University of Brussels and post-doctorate […]
ANAHEIM, Calif,–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Anaheim, California, has named Michael Elniski its new Vice President of Global Sales. Elniski, who most recently served as Franchise VP of Cardiac Critical Care at Merit Medical and was previously VP of Healthcare Solutions at Edwards Lifesciences, is recognized […]
– WatchPAT™ Revenues Increase 15% to $5.8 Million – – U.S. WatchPAT Revenues Increase 34% to $4.3 Million – – Total Revenues Increase 11% to $6.1 Million – CAESAREA, Israel, May 21, 2019 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq & TASE: ITMR), a company that develops, manufactures and markets non-invasive diagnostic […]
WALTHAM, Mass., May 21, 2019 /PRNewswire/ — Corvidia Therapeutics Inc., a clinical stage biotechnology company, today announced the appointment of Dr. Preston Klassen, M.D., M.H.S. to its Board of Directors. Dr. Klassen is presently Executive Vice President, Head of Research and Development at Arena Pharmaceuticals, Inc. (Nasdaq: ARNA). A nephrologist with more than 20 years […]
Santa Monica, CA, May 20, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that Dr. Jerome B. Zeldis agreed to re-join the Company as an Independent Director, […]
SAN CARLOS, Calif., May 20, 2019 (GLOBE NEWSWIRE) — BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results and business highlights for the first quarter of 2019 and filed its quarterly report on Form 10-Q for the three months ended March […]
VANCOUVER, May 16, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ:NVCN)(TSX:NVCN) announced today that it has closed its previously announced private placement (the “Private Placement”) of (i) a 15% original issue discount convertible debenture (the “Debenture”) with a face value of US$11.5 million, for gross proceeds to the Company of US$9,775,000, and […]
